Meeting
2019 Genitourinary Cancers Symposium
Evaluation of prognostic effects of MSI, PD-L1 and TIL in resected bladder cancer.
Authors
Deniz Tural
Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Istanbul, Turkey
Deniz Tural , Emre Akar , Halil Firat Baytekin , Volkan Tugcuoglu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 465)
DOI
10.1200/JCO.2019.37.7_suppl.465
Abstract #
465
Poster Bd #
K14
Abstract Disclosures
Similar Posters
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Profile of programmed death ligand-1 (PD-L1) expression and PD-L1 gene amplification in Indonesian colorectal cancer patients.
First Author: Akterono dwi Budiyati
Poster
2024 ASCO Annual Meeting
Comparing the somatic, germline, and immune landscapes of upper tract urothelial carcinoma (UTUC) and UC of the bladder (UCB).
First Author: Kit L. Yuen
Poster
2018 ASCO Annual Meeting
Mismatch repair deficiency testing for immune checkpoint therapy: Immunohistochemistry vs microsatellite instability.
First Author: Sucha Sudarsanam
First Author: Paul Raymond Kunk